177
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluations

Perifosine – a new option in treatment of acute myeloid leukemia?

, MSc MRCPI FRCPpath, , MB BCh BAO MRCPI, , MD PhD FRCPI FRCPath, , MD FRCPI FRCPath, , MB BCh BAO MRCPI & , MB MD FRCPI FRCPath
Pages 1315-1327 | Published online: 09 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Benedito A Carneiro, Jason B Kaplan, Jessica K Altman, Francis J Giles & Leonidas C Platanias. (2015) Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia. Cancer Biology & Therapy 16:5, pages 648-656.
Read now

Articles from other publishers (8)

Nne E. Uko, Osman F. Güner, Diane F. Matesic & J. Phillip Bowen. (2020) Akt Pathway Inhibitors. Current Topics in Medicinal Chemistry 20:10, pages 883-900.
Crossref
Yiran Chen, Xiaoling Xie, Anqin Wu, Lei Wang, Yuxing Hu, Honghao Zhang & Yuhua Li. (2018) A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Paul-Alain Jaffrès, Consuelo Gajate, Ana Maria Bouchet, Hélène Couthon-Gourvès, Aurélie Chantôme, Marie Potier-Cartereau, Pierre Besson, Philippe Bougnoux, Faustino Mollinedo & Christophe Vandier. (2016) Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy. Pharmacology & Therapeutics 165, pages 114-131.
Crossref
Maximilian Stahl, Tae Kon Kim & Amer M Zeidan. (2016) Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities. World Journal of Stem Cells 8:10, pages 316.
Crossref
Jie Shen, Yue Hong, Qiong Zhao & Jian-li Zhang. (2015) Preclinical evaluation of perifosine as a potential promising anti-rhabdomyosarcoma agent. Tumor Biology 37:1, pages 1025-1033.
Crossref
Benedito A. Carneiro, Joshua J. Meeks, Timothy M. Kuzel, Mariana Scaranti, Sarki A. Abdulkadir & Francis J. Giles. (2015) Emerging therapeutic targets in bladder cancer. Cancer Treatment Reviews 41:2, pages 170-178.
Crossref
Nadine Houédé & Philippe Pourquier. (2015) Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers. Pharmacology & Therapeutics 145, pages 1-18.
Crossref
Natalie G. Sanders, David J. Sullivan, Godfree Mlambo, George Dimopoulos & Abhai K. Tripathi. (2014) Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity. PLoS ONE 9:8, pages e105817.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.